Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review. | Front Pharmacol | 2023 | 36969852 | PubTator, text mining | PubMed |
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine. | Haematologica | 2023 | 36951168 | PubTator, text mining | PubMed |
| Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 36950684 | PubTator, text mining | PubMed |
| Systematic analysis of the aberrances and functional implications of cuproptosis in cancer. | iScience | 2023 | 36950125 | PubTator, text mining | PubMed |
| Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network. | J Oncol | 2023 | 36949898 | PubTator, text mining | PubMed |
| Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer. | Front Cell Dev Biol | 2023 | 36936694 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma. | Front Genet | 2023 | 36936439 | PubTator, text mining | PubMed |
| Menkes disease complicated by concurrent ACY1 deficiency: A case report. | Front Genet | 2023 | 36936426 | PubTator, text mining | PubMed |
| Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition. | Toxicol Appl Pharmacol | 2023 | 36931439 | PubTator, text mining | PubMed |
| The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression. | Front Oncol | 2023 | 36925927 | PubTator, text mining | PubMed |
| Correction to "Using Imidazo[2,1-b][1,3,4]thiadiazol Skeleton to Design and Synthesize Novel MNK Inhibitors". | ACS Med Chem Lett | 2023 | 36923910 | PubTator, text mining | PubMed |
| Editorial: Novel approaches to study metals in molecular biology. | Front Mol Biosci | 2023 | 36923643 | PubTator, text mining | PubMed |
| The Emerging Translational Potential of MNK Inhibitors for the Treatment of Chronic Pain. | Neuroscience | 2023 | 36922084 | PubTator, text mining | PubMed |
| A cuproptosis-related signature for predicting the prognosis of gastric cancer. | J Gastrointest Oncol | 2023 | 36915443 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem. | Mikrochim Acta | 2023 | 36914921 | PubTator, text mining | PubMed |
| A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. | Front Pharmacol | 2023 | 36909185 | PubTator, text mining | PubMed |
| Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy. | Molecules | 2023 | 36903549 | PubTator, text mining | PubMed |
| Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer. | J Clin Med | 2023 | 36902801 | PubTator, text mining | PubMed |
| Health-Related Quality of Life and Family Functioning of Primary Caregivers of Children with Menkes Disease. | J Clin Med | 2023 | 36902556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=26